News UK plans to invest 'billions' in Essex biosecurity centre The UK government has revealed a plan to open a multibillion-pound biosecurity facility to protect the country from emerging public health threats.
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.